학술논문

EXOASO-C/EBP beta(TM): AN ENGINEERED EXOSOME THERAPEUTIC THAT SELECTIVELY TARGETS MDSCS AND INDUCES POTENT SINGLE-AGENT ANTI-TUMOR ACTIVITY IN CHECKPOINT REFRACTORY TUMOR MODELS
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; NOV 2022, 10 pA1396-pA1396, 1p. Supplement: 2
Subject
Language
English
ISSN
20511426